All Announcements
Weil advises Eli Lilly in its $1.1B acquisition of Dermira
Weil is advising Eli Lilly and Company in its pending $1.1 billion acquisition of Dermira, Inc., a developer of new therapies for chronic skin conditions. The transaction is expected to close in the first quarter of 2020 subject to customary closing conditions.
Read MoreWeil advises Graycliff partners in $350M buyout fund
Weil advises Graycliff Partners in its formation of Graycliff Private Equity Partners IV LP, a private buyout fund focused on North American manufacturing, business services and value-added distribution businesses. The oversubscribed fund closed at its hard cap of $350 million in limited partner commitments.
Read MoreWeil advises Cornell Capital and KDC/ONE
Weil is advising Cornell Capital and its portfolio company Knowlton Development Corporation (KDC/ONE), a contract developer, manufacturer and supplier of personal care and household products, in its merger with HCT Group Holdings Limited, a provider of design, engineering, manufacturing, formulation, filling and logistics services for cosmetics products.
Read MoreWeil elects 16 new partners and announces new counsel class
The new partners are based in our Dallas, Frankfurt, Houston, London, New York, Silicon Valley and Washington, D.C. offices.
Read MoreWeil advises TPG Global in acquisition
Weil advises TPG Global in the acquisition by TPG Pace Holdings Corp., a SPAC sponsored by an affiliate of TPG Global, of Accel Entertainment, Inc., a gaming-as-a-service provider.
Read MoreWeil advises Antin infrastructure partners
Weil is advising Antin Infrastructure Partners on the sale of Kellas Midstream to a consortium of BlackRock, a leading institutional investor, and GIC, Singapore’s sovereign wealth fund.
Read MoreJenny Doak added as Weil tax partner
Weil, Gotshal & Manges LLP announces that Jenny Doak will join the Firm as a Tax partner in the London office.
Read More